Supplementary Material for: Decreased Lactococcus lactis and propionic acid in feces of patients with Moyamoya disease: Possible implications of immune dysregulation by figshare admin karger (2628495)

DataSheet_1_Hepatic-Specific Decrease in the Expression of Selenoenzymes and Factors Essential for Selenium Processing After Endotoxemia.docx by Laura G. Sherlock (9602411)

“…Background<p>Selenium (Se) levels decrease in the circulation during acute inflammatory states and sepsis, and are inversely associated with morbidity and mortality. …”

Post spawn total fish weight (mg). by Isaac Adatto (348962)

Data of MG group. by Ye Huang (1482538)

Changes in blood pressure before, during and after regadenoson (RA) infusion. by Joseph Rabin (7399436)

Subjects:

Diagram showing some of the factors that mediate cytokin storm following infection with COVID-19. by Joseph Rabin (7399436)

Subjects:

Changes of plasma proinflammatory cytokines/chemokines during and after RA infusion. by Joseph Rabin (7399436)

Subjects:

Demographics of the COVID-19 patients who received regadenoson treatment. by Joseph Rabin (7399436)

Subjects:

Effects of regadenoson (RA) infusion on oxygen saturation and C-reactive protein (CRP) levels in plasma of COVID-19 patients. by Joseph Rabin (7399436)

Subjects:

Cell proliferation was decreased more by combination treatment of SLCP and BBR than individual treatments. by Panchanan Maiti (1459852)

TOP10 categories most influenced by Tl in the kidney of rats. by Sho Sugahara (11895828)

Decreased transcription of <i>prs</i> results in decreased growth. by Javiera Norambuena (137228)

OJS decreases locomotor activity and increases sleep time during the night cycle in the AOM/DSS model. by Patrice Cunningham (12914917)

Fig 10 - by Koffi Djaman (3374105)

Supplementary Material for: SGLT2 inhibitors decrease overhydration and proteasuria in patients with chronic kidney disease: a longitudinal observational study by Schork A. (17795387)

“…Results: 42 patients (29 % with diabetic/hypertensive CKD, 31 % with IgA nephropathy; 88 % dapagliflozin 10 mg, 10 % dapagliflozin 5 mg, 2 % empagliflozin 20 mg; median eGFR 46 mL/min/1.73m² and albuminuria 1911 mg/g creatinine) participated in the study. …”

Supplementary Material for: SGLT2 inhibitors decrease overhydration and proteasuria in patients with chronic kidney disease: a longitudinal observational study by Schork A. (17795387)

“…Results: 42 patients (29 % with diabetic/hypertensive CKD, 31 % with IgA nephropathy; 88 % dapagliflozin 10 mg, 10 % dapagliflozin 5 mg, 2 % empagliflozin 20 mg; median eGFR 46 mL/min/1.73m² and albuminuria 1911 mg/g creatinine) participated in the study. …”

Complete data. by Jan Víteček (11434774)

“…The rt-PA became increasingly less efficient for clots larger than 50 μl at a clinically relevant concentration of 1.3 mg/l. A tenfold decrease or increase in concentration induced only a 2-fold decrease or increase in clot degradation. …”

Fig 4 - by Jan Víteček (11434774)

“…The rt-PA became increasingly less efficient for clots larger than 50 μl at a clinically relevant concentration of 1.3 mg/l. A tenfold decrease or increase in concentration induced only a 2-fold decrease or increase in clot degradation. …”

Stability of Plasmonic Mg-MgO Core–Shell Nanoparticles in Gas-Phase Oxidative Environments by Vladimir Lomonosov (15213945)

“…Furthermore, we show that the reactivity of Mg-MgO nanoplates with water vapor (3.5 vol % in N₂) decreases with temperature, with no oxidation of the Mg core detected from 200 to 400 °C. …”

Stability of Plasmonic Mg-MgO Core–Shell Nanoparticles in Gas-Phase Oxidative Environments by Vladimir Lomonosov (15213945)

“…Furthermore, we show that the reactivity of Mg-MgO nanoplates with water vapor (3.5 vol % in N₂) decreases with temperature, with no oxidation of the Mg core detected from 200 to 400 °C. …”